Launch week offerEnds in00h00m00s

annual Promonthly Pro

Nasser Alorfi

umm al-qura university

Saudi Arabia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Collaborators (10)

Yahya A Alzahrani

Assistant proffesor

king abdulaziz university

SAUDI ARABIA

View details

Maan Harbi

Assistant professor

umm al-qura university

SAUDI ARABIA

View details

Saad Wali

Assistant Professor

umm al-qura university

SAUDI ARABIA

View details

Nouf Alourfi

king abdulaziz university

SAUDI ARABIA

View details

Mohammed Saed Alharthi

Assistant Professor

taif university

SAUDI ARABIA

View details

Khaled Alam-ElDein

Lecturer

Badr University in Cairo

EGYPT

View details

Fahad T Alsulami

Assistant Professor

taif university

SAUDI ARABIA

View details

Fahad S. Alshehri

Associate professor

umm al-qura university

SAUDI ARABIA

View details

Shaker Alsharif

Assistant Professor

umm al-qura university

SAUDI ARABIA

View details

Ahmed Ashour

Associate Proffesor

umm al-qura university

SAUDI ARABIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nasser Alorfi

Research Interests

Make your next move.

Articles (20)

Pharmacists’ Perspectives on Functional Medication-Use Challenges and Potential Adaptations for People with Disabilities in Saudi Arabia: A Qualitative Study

Pregabalin-associated adverse drug reactions

pH-Responsive Carboxymethyl Cellulose-Encapsulating Hesperidin–Selenium Nanoparticles Attenuate Paracetamol-Induced Acute Kidney Injury via Keap-1/Nrf2, NF-κB, and Mitochondrial Apoptosis Modulation

Therapeutics for Rheumatoid Arthritis: A Phase 4 Clinical Trial Analysis With a Focus on Disability Outcomes

Disability-, Rehabilitation-, and Function-related ClinicalTrials.gov Studies in Saudi Arabia: A Registry-based Cross-sectional Analysis

Neuroplasticity-Driven Rehabilitation Strategies in Disability-Related Locomotor Disorders: A ClinicalTrials.gov-Based Analysis

Pharmacologic and Supportive Therapies for Acute Spinal Cord Injury Disability: A Registry-Based Clinical Trial Analysis

Pharmacological and device-based interventions for paraplegia: A ClinicalTrials.gov-based analysis

Patient Attitudes and Factors Associated with Willingness to Deprescribe Prescribed Medications in Western Saudi Arabia: A Cross-Sectional Study

Tirzepatide vs. semaglutide for obesity, glycemic control, and cardiovascular outcomes: a narrative review of clinical trials

Exploring the Use of GLP-1-Based Interventions for Obesity: A Qualitative Analysis of ClinicalTrials.gov Data

GLP-1 Receptor Agonist Therapy in Older Adults with Diabetes: A Qualitative Analysis of Phase 4 ClinicalTrials.gov Studies

Global pharmacovigilance overview of adverse drug reactions associated with propofol

Translation, cultural adaptation, and psychometric validation of the WHO-5 well-being index for Arabic-speaking university students

Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports

Pharmacological Interventions in the Management of Sports Injuries: A Review of Clinical Use, Dosage Forms, and Anti-Doping Considerations

Characteristics of Completed ClinicalTrials.gov Trials Investigating Neurogenic Bowel Dysfunction Among Individuals with Neurological Disabilities: A Registry-based Analysis

Knowledge, Attitudes, and Clinical Preparedness for Autism Spectrum Disorder Pharmacotherapy Among Pharmacy Students and Recent Graduates in Saudi Arabia: A Multi-regional Cross-sectional Survey

Global trends and gaps in pharmacogenetic clinical trials: A cross-sectional analysis of ClinicalTrials.gov registrations

Pharmacists’ roles and perceptions in managing prenatal exposure to medications: A qualitative study

Collaborators (10)

Yahya A Alzahrani

Maan Harbi

Saad Wali

Nouf Alourfi

Mohammed Saed Alharthi

Khaled Alam-ElDein

Fahad T Alsulami

Fahad S. Alshehri

Shaker Alsharif

Ahmed Ashour

Make your next move.